Indonesia began testing on 1,600 volunteers a vaccine against the coronavirus developed by the Chinese laboratory Sinovac Biotech on Tuesday.
Called Coronavac, it is one of the few vaccines to be in phase III, the last stage of clinical trials before approval. The governor of West Java province, Indonesia’s most populous, is among the volunteers scheduled to take part in the clinical trials scheduled to last until February.
Indonesia, which is the fourth most populous country on the planet, is facing an increase in the number of cases of Covid-19 which has already infected more than 127,000 people and killed more than 5,700 in the country. The scale of the epidemic could be much greater, however, as the detection rate is low in this Southeast Asian country.
If, at the end of these tests, the vaccine proves to be safe and effective, the Indonesian authorities have planned to produce up to 250,000 million doses for this vast archipelago of nearly 270 million inhabitants.
Note that this vaccine is already being tested with 9,000 volunteers in Brazil, the second country most affected in the world by the coronavirus pandemic, after the United States.